Boston Globe
Boston Globe reporter Felicia Gans writes that a number of MIT researchers have been honored “by the Breakthrough Prize organization, which honors scientists worldwide for their pioneering research.”
Boston Globe reporter Felicia Gans writes that a number of MIT researchers have been honored “by the Breakthrough Prize organization, which honors scientists worldwide for their pioneering research.”
Prof. Edward Boyden has been honored as one of the recipients of the Breakthrough Prize, reports Sarah McBride for Reuters. Boyden is being recognized for his work “developing and implementing optogenetics,” writes McBride, which could open “a new path to treatments for Parkinson’s, depression, Alzheimer’s and blindness.”
Tina Casey reports for Popular Science that several MIT researchers have been honored with Breakthrough Prizes. Casey writes that Prof. Edward Boyden was honored for his work creating optogenetics, Prof. Joseph Formaggio and his team were honored for their research on neutrinos, and Profs. Larry Guth and Liang Fu won New Horizons Prizes.
In an article for The New Yorker, Michael Specter writes about Prof. Feng Zhang and his work with CRISPR. Specter writes that Zhang was first inspired to pursue a career in science when he attended Saturday morning molecular biology classes as a middle school student. Zhang recalls that the class, “really opened my imagination.”
STAT reporter Sharon Begley profiles Prof. Feng Zhang. Begley writes that Zhang’s “discoveries could finally bring cures for some of the greatest causes of human suffering, from autism and schizophrenia to cancer and blindness.”
In this BBC News segment, Prof. Robert Langer, winner of the Queen Elizabeth Prize for Engineering, discusses his work exploring how to get the human body to respond to vital drugs. Langer explains that his approach to medicine is to “come up with engineering solutions to different medical problems.”
MIT researchers have engineered viruses that take advantage of quantum physics, mimicking the process of photosynthesis, to enhance energy transfer, reports Alexandra Ossola for Popular Science. The work could result in “solar panels that transmit energy with unprecedented efficiency,” writes Ossola.
Alexandra Ossola writes for Popular Science that MIT researchers have found a molecule that could make the CRISPR gene-editing technique more precise. The new molecule “makes the editing process easier to control and could create new possibilities for how scientists can edit DNA in the future.”
Boston Globe reporter Sharon Begley writes that Prof. Feng Zhang has uncovered enzymes that could be used to edit genes more precisely than the proteins currently used by CRISPR. Begley explains that the discovery means that CRISPR could become an “even more powerful tool to reveal the genetic defects underlying diseases and to perhaps repair them.”
In an article for Wired, Sarah Zhang writes that MIT researchers have identified a new gene-editing system that could prove more effective than current techniques. The new system involves, “a different protein that also edits human DNA, and, in some cases, it may work even better than Cas9,” the protein used for DNA editing.
This video produced by The Wall Street Journal examines new research by MIT scientists showing how the soft palate plays a key role in the transmission of the flu. “The discovery should help scientists better understand the characteristics of flu viruses that have the ability to travel through the air.”
In this video, PBS explores a new technique MIT researchers developed to enlarge brain samples, making them easier to image at high resolutions. Prof. Ed Boyden explains that he hopes the technique could be used to “hunt down very rare things in a tissue.”
In a Boston Globe article about the high level of patent activity in Massachusetts, Emeralde Jensen-Roberts highlights MIT postdoctoral fellow Keith Hearon’s work developing a new type of biodegradable styrofoam, which he is patenting. “Now in the development phase, Hearon believes the citrus plastic with styrofoam has vast potential for larger-scale applications, thanks to its strength.”
MIT biologists have developed a genetically modified version of a common gut bacteria that could be used to treat disease, reports Catherine Woods for the PBS NewsHour. “You could engineer a Bacteroides to live in the gut and detect when inflammation is just starting…so that you can seek treatment right away,” explains Prof. Timothy Lu.
Researchers at MIT have developed tools that could one day allow intestinal bacteria to monitor, diagnose and treat diseases, writes Eryn Brown for The Los Angeles Times. "Just as you'd program computers, we're starting to learn how to program cells by modifying their DNA," says Prof. Timothy Lu.